Molecules and Cells · 2001 · 21 citations · 45 references
Life SciencesImmunologyInfectious DiseasesAdaptive ImmunityCancer ImmunologyVaccinologyDna VaccinesNucleic Acid VaccinesTumor-associated AntigensVector-based VaccinesViral VaccinesViral Vector VaccinesAntibodiesAntibody-dependent Cell-mediated CytotoxicityAntibody-dependent Cellular CytotoxicityCellular Immune PrimingGlycoprotein VaccinesPlasmid Vaccine VectorsPlasmid Vector ConstructionT-cell Immune Responses
Epstein-Barr virus (EBV) is a human pathogen that is involved in numerous diseases and tumors. Since the EBV infection occurs in the early ages of life, and most of the population is subsequently exposed to EBV, the conventional method of vaccination to induce the prophylactic immunity cannot be considered effective in coping with the virus infection. In this study, we tested whether the injection of a plasmid vector that contained the gene for glycoprotein 350 (gp350), which had been identified as a ligand for virus' adsorption and a target for virus neutralizing antibodies, could induce effective immune responses against the antigen. As a result, the injection of the constructed plasmid vector into mice induced the production of gp350-specific antibodies. A major isotype of the gp350-specific antibodies was IgG1. The antibodies efficiently mediated the antibody-dependent cellular cytotoxicity against the cells expressing the gp350 antigen. In addition, the injection of the constructed plasmid vector stimulated the precursor T cell population that was specific to the gp350 antigen. In addition, gp350-specific cytotoxic T lymphocytes were efficiently stimulated by the injection of the constructed plasmid vector. These results suggested that the injection of the plasmid vector, containing the gp350 gene of Epstein-Barr virus, could be one of the most effective ways to induce both prophylactic and therapeutic vaccinations against the virus infection.
45
Mario A. Anzano, Anita B. Roberts, Joseph M. Smith et al. · Proceedings of the National Academy of Sciences · 1983 · 379 citations · Full text